Mr. Han Tianlei, the Life Sciences industry manager of the Swiss company, Endress+Hauser. He's responsible for the company's strategic planning, marketing and major project support in life sciences industry here in China. Based on years of project experience, he is well acquainted with the requirements of typical processes, instrument selection, regulations and certificates in the pharmaceutical and biopharmaceutical industries. At the same time, he also participated in some of the Group's overseas projects, and thus has an understanding of the development and trends of life sciences industry globally.

Heartbeat technology contributes to pharmaceutical safety

From "Industry 4.0", "Made in China 2025" to "Pharma 4.0", these concepts about smart manufacturing have always been a hot topic. However, although the concept is beautiful, it is rare to actually implement it, reduce operating costs, shorten the time to market, improve product quality, and ultimately produce visible benefits. I believe that many people, like me, can't help but think, what is the core of smart manufacturing? Is the more complex the system, the smarter and safer the factory is? Is smart manufacturing really suitable for pharmaceutical industry? Can smart manufacturing really improve the safety and compliance of pharmaceuticals? I would like to take this opportunity to discuss these issues with you. I would like to show some of the explorations we have done in this field. At the bottom of the control system, that is, within the sensors, how to use some advanced technology to bring revolutionary progress to the operation and pre-maintenance of the pharmaceutical factory. We call it Heartbeat technology.